Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Pharmaids Pharmaceuticals Ltd

Your Vote -

Buy

60.00%

Hold

30.00%

Sell

10.00%

60.00%

10 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Pharmaids Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Pharmaids Pharma - Submission Of Audited Financial Results Along With Auditors Report For The Quarter And Year Ended 31St Mar

    23 May 2025, 5:06PM Submission of Audited Financial Results along with Auditors report.
  • Pharmaids Pharma - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31St, 2025

    23 May 2025, 5:05PM The Board of Directors of the Company have approved the Audited Financial Results for the Quarter and Year ended March 31st 2025 at their meeting held
  • Pharmaids Pharma - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Conso

    20 May 2025, 11:08AM Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to con
  • Pharmaids Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    17 Apr 2025, 4:10PM As of March 2025, 5.22% is owned by Indian Promoters and 94.78% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ph
  • Pharmaids Pharma - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    9 Apr 2025, 3:21PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Pharmaids Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    4 Apr 2025, 12:36PM Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended March 31, 2025.
  • Pharmaids Pharma - Intimation Of Loan Agreement

    28 Mar 2025, 4:13PM Disclosure under Regulation 30 of SEBI (LODR) Regulation, 2015 - Intimation of Loan agreement
  • Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    26 Mar 2025, 6:35PM This is to inform you that shareholders of the company approved the Re-appointment of Mr.Venu Madhava Kaparthy (DIN: 00021699) and Ms.Mini Manikantan
  • Pharmaids Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    26 Mar 2025, 5:55PM Further to our letter dated February 19, 2025, please find enclosed the Scrutinizer's Report along with the proceedings of the Meeting held by way of
  • Pharmaids Pharma - Intimation Under Regulation 8(2) Of SEBI (PIT) Regulation, 2015 Regarding Amendment In Fair Disclosure Cod

    24 Mar 2025, 6:22PM Intimation under Regulation 8(2) of SEBI (PIT) Regulation, 2015 regarding Amendment in Fair Disclosure Code.

Key fundamentals

Evaluate the intrinsic value of Pharmaids Pharmaceuticals Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 83.5609 22.4252 8.6715 8.5264 8.4331
Liabilities 83.5609 22.4252 8.6715 8.5264 8.4331
Equity 35.2678 21.4438 10.2688 10.2688 10.2688
Gross Profit -6.3711 -9.8862 0.137 0.1069 -0.3355
Net Profit -4.9498 -7.5556 0.1451 0.0933 0.0335
Cash From Operating Activities -3.4432 -4.0193 -0.2593 0.4053 -0.7475
NPM(%) -17805.03 0 3.68 1.09 0
Revenue 0.0278 0 3.9392 8.551 0
Expenses 6.3989 9.8862 3.8021 8.444 0.3355
ROE(%) -7.37 -11.25 0.21 0.13 0.04

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Pharmaids Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 860.30 1.17 28.42 33.73 301.39 0.58
Lotus Eye Hospital and Institute Ltd 74.49 0.46 210.60 122.91 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 26.01 1.17 0.00 255.19 -39.50 0.00
Astec Lifesciences Ltd 813.25 0.49 0.00 115.89 -687.10 0.00

Company Info

The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.

The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.

Read More

Parent Organisation

Pharmaids Pharmaceuticals Ltd.

Founded

01/03/1989

Managing Director

NSE Symbol

FAQ

The current price of Pharmaids Pharmaceuticals Ltd is

The 52-week high for Pharmaids Pharmaceuticals Ltd is

The market capitalization of Pharmaids Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Pharmaids Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Pharmaids Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Pharmaids Pharmaceuticals Ltd shares.

The CEO of Pharmaids Pharmaceuticals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT